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Prognostic Value of Functional Performance for
Mortality in Patients With Peripheral Artery Disease
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Objectives Among persons with lower extremity peripheral artery disease (PAD), we determined whether objective mea-
sures of walking performance predict mortality independently of the ankle brachial index (ABI).
Background The ability of office-based functional performance measures to predict mortality in patients with PAD is
unknown.
Methods Participants were 444 persons with PAD followed prospectively for 4.8 years. The 6-min walk and 4-m
walks at usual and fastest pace were measured at baseline. Cox proportional hazard models were used to
assess relations between baseline measures of lower extremity performance with mortality, adjusting for
confounders.
Results One hundred twenty-seven patients (28.6%) died during follow-up. Adjusting for age, gender, race, comorbidities,
ABI, and other confounders, participants in the poorest baseline quartile of 6-min walk performance had signifi-
cantly increased total mortality (hazard ratio [HR] 2.36 [95% confidence interval (CI) 1.33 to 4.18]) and cardio-
vascular mortality (HR 5.59 [95% CI 1.97 to 15.9]) compared with the best quartile of baseline performance.
Participants in the poorest baseline quartile of normal-paced 4-m walking speed had significantly increased total
mortality (HR 1.86 [95% CI 1.06 to 3.29]) and cardiovascular mortality (HR 2.55 [95% CI 1.01 to 6.46]) com-
pared with the best quartile of baseline performance.
Conclusions This study demonstrates for the first time that performance-based measures, which can be administered in an office
setting, provide prognostic information regarding mortality in persons with PAD beyond that provided by the
ABI. (J Am Coll Cardiol 2008;51:1482–9) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.12.034p
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oower extremity peripheral artery disease (PAD) affects 8
illion men and women in the U.S. (1). Men and women
ith PAD have significantly increased all-cause and cardio-
ascular mortality rates compared with persons without
AD (2). Among persons with PAD, lower ankle brachial
ndex (ABI) values are associated with increased mortality
ompared with higher ABI values (3).
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007, accepted December 5, 2007.In addition, men and women with PAD have poorer
erformance on objective measures of lower extremity func-
ioning compared with persons without PAD (4–6). Cur-
ently, the prognostic significance of functional impairment
or total and cardiovascular mortality in persons with PAD
s unknown. Therefore, in a prospective observational study,
e assessed whether lower extremity performance predicts
otal and cardiovascular disease mortality in persons with
AD. We hypothesized that among persons with PAD,
hose with poorer functional performance at baseline would
ave higher mortality during follow-up, independent of the
BI and other confounders. Associations of functional
erformance with mortality were also studied in a cohort of
articipants without PAD to determine whether associa-
ions of functional performance and mortality were similar
n persons with versus without PAD.
Functional performance measures, such as the 6-min
alk test and usual walking speed over 4 m, are reliable,
bjective measures of lower extremity functioning that
an be administered in the office setting (7,8). They
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April 15, 2008:1482–9 Mortality in PADequire minimal time and only a stopwatch to administer.
f functional performance predicts mortality, then clinicians
ould potentially use functional performance to identify
ersons with PAD who are at increased risk for mortality.
ethods
articipant identification. The institutional review boards of
orthwestern University and Catholic Health Partners Hospital
pproved the protocol. Participants gave written informed
onsent.
Participants were part of WALCS (Walking and Leg
irculation Study) (4,5), a prospective, observational study
esigned to identify predictors of functional decline and
ortality in PAD. Participants with PAD were identified
rom among consecutive patients age 55 years and older in
Chicago-area noninvasive vascular laboratories. Partici-
ants without PAD were identified from among consecutive
ersons with normal lower extremity arterial studies in the 3
oninvasive vascular laboratories and from a large general
nternal medicine practice at Northwestern University. Median
ollow-up for this report was 57.7 months (interquartile
ange 37.5 to 62.0 months). Participants with PAD had an
BI 0.90 at their baseline visit. Participants without
AD had an ABI of 0.90 to 1.50. Exclusion criteria have
een reported (5). In addition, in the WALCS cohort of
60 participants with PAD and 280 without PAD, 4
AD participants who did not undergo baseline func-
ional performance data were excluded. An additional 12
AD and 8 non-PAD participants were excluded because
hey had missing data for covariates in our fully adjusted
odel.
BI measurement. A handheld Doppler probe (Nicolet
ascular Pocket Dop II, Nicolet Biomedical Inc., Golden,
olorado) was used to obtain systolic pressures in the right
nd left brachial, dorsalis pedis, and posterior tibial arteries
4,5). Each pressure was measured twice. The ABI was
alculated by dividing the mean of the dorsalis pedis and
osterior tibial pressures in each leg by the mean of the 4
rachial pressures (9). Average brachial pressures in the arm
ith highest pressure were used when 1 brachial pressure
as higher than the opposite brachial pressure in both
easurement sets and the 2 brachial pressures differed by 10
m Hg or more in at least 1 measurement set, because in
uch cases subclavian stenosis was possible (4,5). Zero values
or the dorsalis pedis or posterior tibial vessels (n 29) were
xcluded from the ABI calculation. The lowest leg ABI was
sed in analyses.
omorbidities. Comorbidities assessed were diabetes, an-
ina, myocardial infarction, heart failure, cancer, chronic
ung disease, and stroke. Disease-specific algorithms that
ombine data from patient report, medical record review,
edications, laboratory values, and a questionnaire com-
leted by the participant’s primary care physician were used
o verify and document baseline and incident comorbidities,
ased on criteria previously developed (10). bther measures. Body mass
ndex (BMI) was calculated as:
eight (kilograms)/(height [me-
ers])2. Pack-years of cigarette
moking and history of hyperten-
ion were determined with the
atient report.
unctional measures. 6 -M I N
ALK. Following a standardized
rotocol (4,5,11), participants
alked up and down a 100-foot hallway for 6 min after
nstructions to cover as much distance as possible.
EPEATED CHAIR RISES. Participants sit in a straight-
acked chair with arms folded across their chest and stand
times consecutively as quickly as possible. Time to
omplete 5 chair rises was measured (7,8).
TANDING BALANCE. Participants were asked to hold 3 in-
reasingly difficult standing positions for 10 s each: standing
ith feet together side-by-side and parallel (side-by-side
tand), standing with feet parallel with the toes of 1 foot
djacent to and touching the heel of the opposite foot
semi-tandem stand), and standing with 1 foot directly in
ront of the other (tandem stand) (7,8).
-M WALKING VELOCITY. Walking velocity was measured
ith a 4-m walk performed at “usual” and “fastest” pace
4,5,7,8). For the “usual” paced walk, participants were
nstructed to walk at their usual pace, “as if going down
he street to the store.” Each walk was performed twice. The
aster walk in each pair was used in analyses (7,8).
HORT PHYSICAL PERFORMANCE BATTERY (SPPB). The
PPB combines data from the usual paced 4-m walking
elocity, time to rise from a seated position 5 times, and
tanding balance. Individuals receive a zero score for each
ask they are unable to complete. Scores of 1 to 4 are
ssigned for remaining tasks, based on quartiles of
erformance for over 6,000 participants in the Estab-
ished Populations for the Epidemiologic Study of the
lderly (7,8). Scores are summed to obtain the SPPB,
anging from 0 to 12.
ATIENT-REPORTED PHYSICAL ACTIVITY MEASURES. At
he initial visit, participants were asked, “During the last
eek, how many city blocks or their equivalent did you
alk? Let 12 city blocks equal 1 mile.” Participants were also
sked, “In the last week, about how many flights of stairs did
ou climb up? A flight is 10 steps.” Participants were asked
o report the number of times they went walking for exercise
uring the prior week. These measures of patient-reported
hysical activity have been previously shown to be highly
orrelated with objectively-assessed physical activity mea-
ured with vertical accelerometers (12).
eath. We used the Social Security Administration death
atabase to search for deaths through June 27, 2005. At
Abbreviations
and Acronyms
ABI  ankle brachial index
BMI  body mass index
PAD  peripheral artery
disease
SPPB  short physical
performance batteryaseline, each participant provided names of 3 proxies not
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Mortality in PAD April 15, 2008:1482–9iving with them to assist with ascertaining complete
ollow-up data. Information on deaths was also obtained
rom family members, proxies, and primary care physicians.
eath certificates were obtained from the State of Illinois or
rom the patients’ medical records. Cardiovascular disease
eaths were those with International Classification of
isease-10 codes in the range I01.0 through I99.9, includ-
ng deaths due to coronary heart disease, stroke, peripheral
ascular disease, and other cardiovascular disease.
tatistical analyses. Among persons with PAD, baseline
haracteristics between decedents and survivors were com-
ared using general linear models for continuous variables
nd chi-square tests for categorical variables, adjusting for
ge and gender (Table 1). Next, proportional hazards
nalyses were used to compare differences in all-cause
ortality across categories of baseline lower extremity per-
ormance. In these proportional hazards analyses, categories
f lower extremity performance (independent variables of
nterest) were defined as follows. Among persons with and
ithout PAD, respectively, performance on the 6-min walk
nd usual and fast-paced 4-m walking velocity test was
ategorized into quartiles. The fourth quartile represented best
unctional performance, and the first quartile represented the
oorest functional performance. A priori, the baseline SPPB
as categorized as follows: category 1 (SPPB  0 to 4),
ategory 2 (SPPB  5 to 8), category 3 (SPPB  9 to 11),
ategory 4 (SPPB  12). Among participants with and
ithout PAD, respectively, proportional hazards analyses
ere performed to determine associations of these baseline
ategories of functional performance with all-cause mortal-
ty, adjusting for age and gender. Next, these proportional
azards analyses were repeated with additional adjustment
or race, comorbidities (diabetes, angina, myocardial infarc-
ion, heart failure, cancer, lung disease, and stroke), cigarette
moking (pack-years), BMI, and ABI (PAD participants
nly). These fully-adjusted proportional hazards analyses
ere repeated among participants with PAD after excluding
eaths during the first year of follow-up and after excluding
articipants with baseline ABI 0.40, respectively.
ge- and Gender-Adjusted Characteristics of Participants With PAD
Table 1 Age- and Gender-Adjusted Characteristics of Participan
All PAD Parti
(n  44
African-American race (%) 15.5
Ankle brachial index 0.65
Body mass index (kg/m2) 27.3
Cigarette smoking (pack-years) 39.4
Cardiac or cerebrovascular diseases (%) 59.7
Cancer (%) 16.3
Pulmonary disease (%) 32.4
Diabetes (%) 30.7
Number of blocks walked during the past 7 days 33.4
Number of stair flights climbed during the past 7 days 17.39or ankle brachial index, body mass index, cigarette smoking, and physical activity levels, values shown
PAD  peripheral artery disease.The proportional hazards analyses described above were
epeated among participants with and without PAD, respec-
ively, for the dependent variable of cardiovascular mortality.
gain, quartiles of baseline performance on the 6-min walk
est and the 4-m walking velocity tests (usual and fastest pace)
ere independent variables of interest for analyses of PAD and
on-PAD participants, respectively. Because of few cardiovas-
ular deaths among participants with baseline SPPB scores of
to 4, the lowest (poorest) category for the SPPB in these
nalyses was defined as SPPB  0 to 8. Proportional hazards
nalyses were performed among persons with and without
AD, respectively, to determine associations of baseline cate-
ories of lower extremity performance with cardiovascular
isease mortality, adjusting for age and gender. These propor-
ional hazards analyses were repeated with additional adjust-
ent for race, comorbidities (diabetes, angina, myocardial
nfarction, heart failure, cancer, lung disease, and stroke),
igarette smoking (pack-years), BMI, and ABI (PAD partic-
pants only). The causes of 23 of 127 deaths in participants
ith PAD and 9 of 47 deaths in persons without PAD were
nknown because of missing death certificates. We employed
ultiple imputation methods (10 repeated imputations were
sed in the analyses) in competing risk analyses to handle the
issing cause of death when death certificates were unobtain-
ble (13). Missing data were considered to be missing at
andom, in that the conditional probability of cardiovascular
eath among participants with missing death certificates can be
odeled using logistic regression with a set of baseline covari-
tes as independent variables. We repeated analyses for cardio-
ascular mortality, first assuming that none of the missing
auses of death were due to cardiovascular disease and then
ssuming that all missing causes of death were due to cardiovas-
ular disease. Analyses were performed using SAS statistical
oftware (version 9.1, SAS Institute Inc., Cary, North Carolina).
esults
f the 444 PAD participants included in analyses, 127
28.6%) died during follow-up. Among the PAD partici-
ants with a known cause of death, 43% were due to
ording to Survivor Status
ith PAD According to Survivor Status
s Survivors
(n  317)
Decedents
(n  127) p Value
13.4 21.0 0.058
0.66 (0.008) 0.63 (0.013) 0.048
27.5 (0.268) 26.7 (0.427) 0.119
38.8 (1.90) 40.7 (3.02) 0.608
55.4 70.3 0.006
13.1 24.4 0.006
29.0 41.0 0.020
25.7 43.3 0.001
34.7 (3.13) 30.0 (5.00) 0.424
18.4 (1.50) 14.8 (2.39) 0.196Acc
ts W
cipant
4)are mean (SE). Categorical variables are expressed in percentage.
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April 15, 2008:1482–9 Mortality in PADardiovascular disease and 29% were due to cancer. Of the 272
articipants without PAD, 47 (17.3%) died during follow-up.
mong the non-PAD participants with a known cause of
eath, 36% were due to cardiovascular disease.
The average age of participants was 71.9  8.4 years for
hose with PAD and 69.4  8.1 years for those without
AD. Among PAD participants, 40.1% were women,
6.2% were African American, and 31.5% had diabetes
ellitus. Among participants without PAD, 48.2% were
omen, 18.8% were African American, and 21.0% had
iabetes mellitus.
Table 1 shows baseline characteristics of survivors and
ecedents with PAD, adjusting for age and gender. Among
articipants with PAD, survivors were older (74.1  8.78
ears vs. 71.0  8.03 years, p  0.0003) and were likely to
e men (68.5% vs. 56.5%, p  0.019) compared with
ecedents. Decedents had lower ABI values and higher
revalences of cardiac or cerebrovascular diseases, cancer,
ulmonary disease, and diabetes.
unctional performance and mortality in persons with-
ut PAD. Among participants without PAD, poorer base-
ine 6-min walk performance was associated significantly
ith higher all-cause mortality and cardiovascular disease
ortality in proportional hazards analyses adjusting for age
Figure 1 Associations of Functional Performance With All-Caus
Model 1: results of proportional hazards analyses adjusting for age and gender; M
comorbidities (cardiovascular diseases, pulmonary disease, cancer, and diabetes)
peripheral artery disease.nd gender (p trend  0.03 and 0.01, respectively). Among
articipants without PAD, there were no other significant
ssociations between baseline functional performance and
ll-cause or cardiovascular disease mortality either in pro-
ortional hazards analyses that adjusted for age and gender
r in proportional hazards analyses adjusting for age, gen-
er, race, comorbidities, BMI, and cigarette smoking (data
ot shown). Results for cardiovascular mortality were sim-
lar when the missing causes of death were assumed to be
oncardiovascular disease related, when missing causes of
eath were all assumed to be due to cardiovascular disease,
nd when cause of death was imputed for those missing
data not shown). There were no significant interactions
etween presence versus absence of PAD and the associa-
ion of functional performance measures with mortality
data not shown).
unctional performance and mortality in persons with
AD. In proportional hazards analyses of PAD partici-
ants adjusting for age and gender, significant, linear
ssociations between poorer baseline performance and
igher all-cause mortality were observed for the 6-min walk
p trend0.001), usual paced 4-m walking velocity (p trend
0.001), fast-paced 4-m walking velocity (p trend 
.002), and the SPPB (p trend  0.002) (Fig. 1, Model 1).
rtality Among Persons With PAD (n  444)
: results of proportional hazards analyses adjusting for age, gender, race,
mass index, cigarette smoking history, and the ankle brachial index. PAD e Mo
odel 2
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Mortality in PAD April 15, 2008:1482–9n proportional hazards analyses of PAD participants ad-
usting for age, gender, race, ABI, BMI, smoking, and
omorbidities, significant, linear associations between poorer
aseline performance and higher all-cause mortality were
bserved for 6-min walk performance (p trend  0.001),
sual-paced 4-m walking velocity (p trend  0.021), and
ast-paced 4-m walking velocity (p trend  0.029) (Fig. 1,
odel 2).
In Cox proportional hazards analyses adjusting for age
nd gender, significant, linear associations between poorer
aseline performance and higher cardiovascular mortality
ates were observed for the 6-min walk test (p trend
0.001), usual-paced 4-m walking velocity (p trend 
.003), fast-paced 4-m walking velocity (p trend  0.001),
nd the SPPB (p trend  0.026) (Fig. 2, Model 1). Among
AD participants, associations of poorer 6-min walk per-
ormance with greater cardiovascular disease mortality re-
ained statistically significant in Cox proportional hazards
nalyses adjusting for age, gender, race, ABI, BMI, smok-
ng, diabetes, angina, myocardial infarction, heart failure,
ancer, lung disease, and stroke (p trend 0.001). Signifi-
ant associations of slower fast-paced 4-m walking velocity
ith higher cardiovascular mortality rates were also ob-
Figure 2 Associations of Functional Performance With Cardiova
Model 1: results of proportional hazards analyses adjusting for age and gender; M
comorbidities (cardiovascular diseases, pulmonary disease, cancer, and diabetes)
a small number of cardiovascular deaths in patients with short physical performan
pants with a short physical performance battery score of 5 to 8. PAD  peripheralerved in fully adjusted proportional hazard analyses (p
rend  0.014) (Fig. 2, Model 2). Results for cardiovascular
ortality were similar when the missing causes of death
ere all assumed to be noncardiovascular disease related,
hen missing causes of death were all assumed to be due to
ardiovascular disease, and when cause of death was im-
uted for those missing (data not shown).
Table 2 shows results of proportional hazards analyses
erformed to identify associations of functional perfor-
ance measures with all-cause and cardiovascular disease
ortality among persons with PAD, adjusting for physical
ctivity levels in addition to age, gender, race, ABI, BMI,
moking, and comorbidities. Among participants with
AD, associations of poorer 6-min walk performance with
igher all-cause and cardiovascular disease mortality
emained statistically significant in the analyses that
ncluded adjustment for physical activity (Table 2). As-
ociations of slower usual-paced and fast-paced walking
elocity with increased all-cause mortality remained sta-
istically significant in the analyses that included adjust-
ent for physical activity (Tables 3 and 4). Associations
f usual- and fast-paced 4-m walking speed with cardio-
ascular disease mortality were no longer statistically
ar Disease Mortality Among Persons With PAD (n  444)
: Results of proportional hazards analyses adjusting for age, gender, race,
mass index, cigarette smoking history, and the ankle brachial index. Because of
tery scores of 0 to 4, this category was combined with the category of partici-
disease.scul
odel 2
, body
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April 15, 2008:1482–9 Mortality in PADignificant in the proportional hazards analyses that
ncluded additional adjustment for physical activity (Ta-
les 3 and 4).
Because persons with critical limb ischemia have high
ates of mortality, proportional hazards analyses among
AD participants were repeated after excluding participants
ith baseline ABI 0.40. Again, proportional hazards
nalyses adjusted for age, gender, race, BMI, ABI, smoking,
nd comorbidities. Results within this subset of 424 PAD
articipants were largely unchanged. However, associations
f fastest 4-m walking velocity with all-cause and cardio-
ascular disease mortality were no longer statistically sig-
ificant in fully adjusted analyses (p trend  0.096 for
ll-cause mortality, p trend  0.051 for cardiovascular
isease mortality).
Because PAD participants who were ill at baseline were
ikely to have both poorer functional performance and a
igher mortality risk, we repeated proportional hazards
nalyses after excluding PAD participants who died during
he first year of follow-up. Proportional hazards analyses
djusted for age, gender, race, BMI, ABI, smoking, and
omorbidities. A similar, significant trend remained be-
ssociations of Functional Performance Measures With Total and Carti pants With PAD After Additio al Adjustm nt for Physical Act
Table 2 Associations of Functional Performance Measures WitParticipants With PAD After Additional Adjustment for
Baseline 6-min Walk Quartiles
Additional Adjustment for Bloc
During the Past Week
HR (95% CI) p Value
Total mortality
1st quartile (897) 2.40 (1.32–4.38) 0.004
2nd quartile (1,158) 1.57 (0.86–2.86) 0.141
3rd quartile (1,400) 0.98 (0.53–1.81) 0.951
4th quartile (1,400) 1.0 (referent) NA
Cardiovascular mortality
1st quartile (897) 5.36 (1.95–14.8) 0.001
2nd quartile (1,158) 3.80 (1.40–10.3) 0.009
3rd quartile (1,400) 1.60 (0.58–4.45) 0.363
4th quartile (1,400) 1.0 (referent) NA
I  confidence interval; HR  hazard ratio; PAD  peripheral artery disease.
ssociations of Functional Performance Measures With Mortality Aith PAD After Additional Adjust e t for Physical Activity Levels:
Table 3 Associations of Functional Performance Measures WitWith PAD After Additional Adjustment for Physical Act
Normal Paced 4-m Walking Velocity
Additional Adjustment for B
During the Past W
HR (95% CI) p Valu
Total mortality
1st quartile (0.759) 1.85 (1.04–3.29) 0.037
2nd quartile (0.879) 1.72 (0.99–2.97) 0.054
3rd quartile (1.010) 1.29 (0.72–2.32) 0.400
4th quartile (1.010) 1.00 (referent) NA
Cardiovascular mortality
1st quartile (0.759) 2.33 (0.91–5.97) 0.078
2nd quartile (0.879) 2.22 (0.96–5.15) 0.063
3rd quartile (1.010) 2.09 (0.91–4.80) 0.081
4th quartile (1.010) 1.0 (referent) NAbbreviations as in Table 2.ween poorer 6-min walk at baseline and increased all-cause
ortality (p trend  0.002) and cardiovascular disease
ortality (p trend 0.005), even after excluding individuals
ho died during the first year of follow-up. In these
nalyses, the hazard ratio for participants in the lowest
ersus highest quartile of 6-min walk performance at base-
ine was 2.22 (95% confidence interval 1.21 to 4.09, p 
.010) for all-cause mortality and 3.61 (95% confidence
nterval 1.28 to 10.10, p  0.015) for cardiovascular disease
ortality.
iscussion
esults reported here show, for the first time, that poorer
-min walk performance and slower walking velocity iden-
ify persons with PAD who are at increased risk for all-cause
nd cardiovascular mortality. Even after adjustment for
onfounders including the ABI and comorbidities, poorer
-min walk performance and slower walking speed at fastest
ace remained significantly and independently associated
ith higher all-cause and cardiovascular disease mortality
ates. Similarly, even after adjusting for confounders, slower
vascular Mortality AmongLevels: Baseline 6-Min Walk Quartiles
al and Cardiovascular Mortality Among
ical Activity Levels: Baseline 6-Min Walk Quartiles
lked Additional Adjustment for Stair Flights Climbed
During the Past Week
p Trend HR (95% CI) p Value p Trend
0.001 2.33 (1.31–4.16) 0.004 0.001
1.54 (0.86–2.76) 0.149
0.97 (0.53–1.76) 0.912
1.0 (referent) NA
0.001 5.30 (1.79–15.7) 0.003 0.001
3.82 (1.35–10.8) 0.012
1.62 (0.57–4.60) 0.369
1.0 (referent) NA
g Participantsal Paced 4-m Walking Velocity
rtality Among Participants
Levels: Normal Paced 4-m Walking Velocity
Walked Additional Adjustment for Stair Flights Climbed
During the Past Week
p Trend HR (95% CI) p Value p Trend
0.025 1.87 (1.06–3.30) 0.031 0.022
1.73 (1.001–2.98) 0.0497
1.32 (0.73–2.39) 0.356
1.00 (referent) NA
0.146 2.59 (1.04–6.44) 0.041 0.139
2.35 (1.01–5.44) 0.046
2.33 (1.01–5.36) 0.047
1.0 (referent) NAardioivity
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Mortality in PAD April 15, 2008:1482–9sual-paced walking speed was associated with higher all-
ause mortality rates.
Among participants with PAD, associations of 4-m
alking speed with cardiovascular disease mortality were no
onger statistically significant after additional adjustment
or physical activity levels. This finding suggests that higher
hysical activity levels among PAD participants with faster
-m walking speed explained associations of slower 4-m
alking speeds with increased rates of cardiovascular
ortality.
In contrast with findings for persons with PAD, we did
ot find significant associations of functional performance
easures with mortality in persons without PAD after
djusting for age, gender, race, comorbidities, and other
onfounders. However, prior large studies of community-
welling men and women without PAD have demonstrated
ignificant associations of slower usual-walking speed,
oorer SPPB scores, and poorer 400-m walk performance
ith higher mortality (7,14). The lack of association of
unctional performance with mortality in persons without
AD in the WALCS cohort is likely due to the relatively
mall sample size and fewer deaths in participants without
AD. We did not observe a significant interaction between
resence versus absence of PAD and associations of func-
ional performance with mortality.
Persons with PAD have significantly increased rates of
ll-cause and cardiovascular disease mortality compared
ith persons without PAD (2). Clinical practice guidelines
or evaluation and management of persons with PAD
uggest that the ABI should be used to assess risk of
ortality, with lower ABI values being associated with
ncreased risk (15). Results presented here demonstrate that
imple measures of lower extremity functional performance
rovide additional information about mortality risk beyond
hat provided by the ABI and other confounders. These
ndings underscore the importance of measuring functional
erformance in persons with PAD in clinical settings and in
ssociations of Functional Performance With Total and Cardiovascarti pants With PAD After Additio al Adjustment for Physical A t
Table 4 Associations of Functional Performance With Total andParticipants With PAD After Additional Adjustment for
Fast-Paced 4-m Walking Velocity
Additional Adjustment for Blo
During the Past We
HR (95% CI) p Value
Total mortality
1st quartile (1.034) 1.88 (1.03–3.43) 0.041
2nd quartile (1.223) 1.82 (1.04–3.17) 0.036
3rd quartile (1.379) 1.50 (0.84–2.68) 0.176
4th quartile (1.379) 1.0 (referent) NA
Cardiovascular mortality
1st quartile (1.034) 2.29 (0.84–6.25) 0.106
2nd quartile (1.223) 2.40 (0.97–5.94) 0.057
3rd quartile (1.379) 1.37 (0.48–3.92) 0.554
4th quartile (1.379) 1.0 (referent) NA
nalyses adjust for age, gender, race, comorbidities, cigarette smoking, body mass index, and the
Abbreviations as in Table 2.esearch studies including clinical trials. Objective measures pf functional performance can be administered by trained
ealthcare personnel with minimal time and effort.
Previous studies demonstrate that better performance on
bjective measures of lower extremity functioning is associ-
ted with higher physical activity levels and lower rates of
obility loss in persons with PAD (16,17). Higher levels of
hysical activity are associated with lower mortality in
ersons with PAD (12). Results presented here suggest that
ptimal management of patients with PAD should include
fforts to improve functional performance. Previous study
emonstrates that supervised walking exercise programs
mprove 6-min walk performance in persons with PAD and
ntermittent claudication (18). Based on findings presented
ere, future study is indicated to determine whether im-
roving functional performance is associated with lower
ortality in persons with PAD.
Reasons for the independent associations of functional
erformance with mortality even after adjusting for mortal-
ty risk factors could not be discerned from the data
resented here. However, one possible explanation is that
he performance measures provide more sensitive informa-
ion regarding the severity of PAD, severity of concomitant
ardiovascular disease, and perhaps other unmeasured risk
actors compared with the ABI and other clinical charac-
eristics studied.
tudy limitations. First, PAD participants were identified
rom academic medical centers in Chicago. These findings
ay not be generalizable to other PAD patients. However,
here is no reason to believe that the relationships reported
ere would not be observed in other PAD populations.
econd, death certificates were not obtained for 18.1% of
ecedents with PAD. However, a statistical imputation
ethod was performed to account for missing causes of
eath. Findings for our imputation method were similar to
hose in which participants without a cause of death were
xcluded from these analyses. Third, the WALCS cohort
oes not include a measure of renal function, which is a
ortality AmongLevels: Fast-Paced 4-m Walking Velocity
diovascular Mortality Among
ical Activity Levels: Fast-Paced 4-m Walking Velocity
alked Additional Adjustment for Stair Flights Climbed
During the Past Week
p Trend HR (95% CI) p Value p Trend
0.035 1.89 (1.04–3.44) 0.036 0.032
1.82 (1.05–3.17) 0.034
1.53 (0.85–2.74) 0.156
1.0 (referent) NA
0.087 2.54 (0.94–6.89) 0.067 0.071
2.50 (1.01–6.14) 0.047
1.49 (0.51–4.36) 0.470
1.0 (referent) NA
brachial index in addition to the physical activity measures listed at the top of each column.ular Mivity
Car
Phys
cks W
ekotential confounder of associations reported here.
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hese findings indicate that simple, objective measures of
erformance provide prognostic information regarding
ortality in persons with PAD that are not available
rom other clinical data studied. Further study is needed
o determine whether interventions that improve func-
ional performance also improve survival among persons
ith PAD.
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